PPARA and osteosarcoma: On the other hand, TRIM46 acts as an oncogene in osteosarcoma by interacting with and ubiquitinating peroxisome proliferator-activated receptor alpha (PPARα), resulting in the activation of the NF-κB signaling pathway (Jiang et al. 2020).